Unconventional secretion of Ebola virus matrix protein VP40

Journal of Infectious Diseases

Volumn 204, Issue SUPPL. 3, 2011, Pages

  Reynard, Olivier ^a   Reid, St Patrick ^a,d   Page, Audrey ^a   Mateo, Mathieu ^a   Alazard Dany, Nathalie ^a   Raoul, Hervé ^b   Basler, Christopher F ^c   Volchkov, Viktor E ^a  

^a UNIVERSITÉ DE LYON   (France)

^b INSERM   (France)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^d UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OLIGOMER; PROTEIN VP40;

ANIMAL CELL; ARTICLE; CELL DEATH; CONTROLLED STUDY; CULTURE MEDIUM; EBOLA VIRUS; ENDOPLASMIC RETICULUM; GOLGI COMPLEX; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN SECRETION; VIRUS ASSEMBLY; VIRUS LIKE AGENT; VIRUS RELEASE; VIRUS VIRULENCE;

ANIMALS; CERCOPITHECUS AETHIOPS; CULTURE MEDIA; EBOLAVIRUS; ENDOPLASMIC RETICULUM; GENE EXPRESSION REGULATION, VIRAL; GOLGI APPARATUS; HEK293 CELLS; HUMANS; VERO CELLS; VIRAL MATRIX PROTEINS;

EID: 80054720236     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jir305     Document Type: Article

References (32)

1. Harty RN, Brown ME, Wang G, Huibregtse J, Hayes FP. A PPxY motif within the VP40 protein of Ebola virus interacts physically andfunctionally with a ubiquitin ligase: implications for filovirus budding. Proc Natl Acad Sci U S A 2000; 97:13871-6.
2. Timmins J, Scianimanico S, Schoehn G, Weissenhorn W. Vesicular release of Ebola virus matrix protein VP40. Virology 2001; 283:1-6. (Pubitemid 32911504)
3. Warfield KL, Swenson DL, Olinger GG, KalinaWV, AmanMJ, Bavari S. Ebola virus-like particle-based vaccine protects nonhuman primates against lethal Ebola virus challenge. J Infect Dis 2007; 196(suppl 2): S430-7. (Pubitemid 351417291)
4. Ruigrok RW, Schoehn G, Dessen A, et al. Structural characterization and membrane binding properties of the matrix protein VP40 of Ebola virus. J Mol Biol 2000; 300:103-12.
5. Scianimanico S, Schoehn G, Timmins J, Ruigrok RH, Klenk HD, Weissenhorn W. Membrane association induces a conformational change in the Ebola virus matrix protein. Embo J 2000; 19:6732-41. (Pubitemid 32011666)
6. Hoenen T, Volchkov V, Kolesnikova L, et al. VP40 octamers are essential for Ebola virus replication. J Virol 2005; 79:1898-905. (Pubitemid 40459134)
7. Licata JM, Simpson-Holley M, Wright NT, Han Z, Paragas J, Harty RN. Overlapping motifs (PTAP and PPEY) within the Ebola virus VP40 protein function independently as late budding domains: involvement of host proteins TSG101 and VPS-4. J Virol 2003; 77:1812-9. (Pubitemid 36109993)
8. Timmins J, Schoehn G, Ricard-Blum S, et al. Ebola virus matrix protein VP40 interaction with human cellular factors Tsg101 and Nedd4. J Mol Biol 2003; 326:493-502. (Pubitemid 36279343)
9. Yamayoshi S, Noda T, Ebihara H, et al. Ebola virus matrix protein VP40 uses the COPII transport system for its intracellular transport. Cell Host Microbe 2008; 3:168-77. (Pubitemid 351325757)
10. Basler CF, Wang X, Muhlberger E, et al. The Ebola virus VP35 protein functions as a type I IFN antagonist. Proc Natl Acad Sci U S A 2000; 97:12289-94.
11. Prins KC, Delpeut S, Leung DW, et al. Mutations abrogating VP35 interaction with double-stranded RNA render Ebola virus avirulent in guinea pigs. J Virol 2010; 84:3004-15.
12. Mateo M, Carbonnelle C, Reynard O, et al. VP24 is a molecular determinant of virulence in guinea-pigs. J Infect Dis 2011; 204(Suppl 3); S1019-29.
13. Reynard O, Mokhonov V, Mokhonova E, et al. Kunjin virus repliconbased vaccines expressing Ebola virus glycoprotein GP protect the guinea pig against lethal Ebola virus infection. J Infect Dis 2011; 204(Suppl 3);S1068-73.
14. Noda T, Watanabe S, Sagara H, Kawaoka Y.Mapping of the VP40-binding regions of the nucleoprotein of Ebola virus. J Virol 2007; 81:3554-62. (Pubitemid 46456664)
15. Tanudji M, Hevi S, Chuck SL. Improperly folded green fluorescent protein is secreted via a non-classical pathway. J Cell Sci 2002; 115:3849-57. (Pubitemid 35203611)
16. Klausner RD, Donaldson JG, Lippincott-Schwartz J. Brefeldin A: insights into the control of membrane traffic and organelle structure. J Cell Biol 1992; 116:1071-80.
17. Muniz M, Alonso M, Hidalgo J, Velasco A. A regulatory role for cAMPdependent protein kinase in protein traffic along the exocytic route. J Biol Chem 1996; 271:30935-41. (Pubitemid 26404120)
18. Muniz M, Martin ME, Hidalgo J, Velasco A. Protein kinase A activity is required for the budding of constitutive transport vesicles from the trans-Golgi network. Proc Natl Acad Sci U S A 1997; 94:14461-6. (Pubitemid 28041396)
19. Volchkov VE, Volchkova VA, Slenczka W, Klenk HD, Feldmann H. Release of viral glycoproteins during Ebola virus infection. Virology 1998; 245:110-9. (Pubitemid 28384082)
20. Sanchez A, Yang ZY, Xu L, Nabel GJ, Crews T, Peters CJ. Biochemical analysis of the secreted and virion glycoproteins of Ebola virus. J Virol 1998; 72:6442-7. (Pubitemid 28323957)
21. Volchkova VA, Klenk HD, Volchkov VE. Delta-peptide is the carboxyterminal cleavage fragment of the nonstructural small glycoprotein sGP of Ebola virus. Virology 1999; 265:164-71. (Pubitemid 30012395)
22. Bendtsen JD, Jensen LJ, Blom N, Von Heijne G, Brunak S. Featurebased prediction of non-classical and leaderless protein secretion. Protein Eng Des Sel 2004; 17:349-56. (Pubitemid 39093515)
23. Elliott G, O'Hare P. Intercellular trafficking and protein delivery by a herpesvirus structural protein. Cell 1997; 88:223-33. (Pubitemid 28015871)
24. Goldstein G. HIV-1 Tat protein as a potential AIDS vaccine. Nat Med 1996; 2:960-4. (Pubitemid 26306825)
25. Lecellier CH, Vermeulen W, Bachelerie F, Giron ML, Saib A. Intra- and intercellular trafficking of the foamy virus auxiliary Bet protein. J Virol 2002; 76:3388-94. (Pubitemid 34224542)
26. Nickel W. Unconventional secretion: an extracellular trap for export of fibroblast growth factor 2. J Cell Sci 2007; 120:2295-9. (Pubitemid 47232202)
27. Temmerman K, Ebert AD, Muller HM, Sinning I, Tews I, Nickel W. A direct role for phosphatidylinositol-4,5-bisphosphate in unconventional secretion of fibroblast growth factor 2. Traffic 2008; 9:1204-17. (Pubitemid 351916893)
28. Volchkov VE, Chepurnov AA, Volchkova VA, Ternovoj VA, Klenk HD. Molecular characterization of guinea pig-adapted variants of Ebola virus. Virology 2000; 277:147-55.
29. Steele K, Crise B, Kuehne A, Kell W. Ebola virus glycoprotein demonstrates differential cellular localization in infected cell types of nonhuman primates and guinea pigs. Arch Pathol Lab Med 2001; 125:625-30. (Pubitemid 32429808)
30. Ryabchikova EI, Kolesnikova LV, Netesov SV. Animal pathology of filoviral infections. Curr Top Microbiol Immunol 1999; 235:145-73. (Pubitemid 28501321)
31. Leroy EM, Baize S, Debre P, Lansoud-Soukate J, Mavoungou E. Early immune responses accompanying human asymptomatic Ebola infections. Clin Exp Immunol 2001; 124:453-60. (Pubitemid 32701707)
32. Baize S, Leroy EM, Georges-Courbot MC, et al. Defective humoral responses and extensive intravascular apoptosis are associated with fatal outcome in Ebola virus-infected patients. Nat Med 1999; 5:423-6. (Pubitemid 29180581)